![]() |
Volumn 26, Issue 1, 2014, Pages 7-9
|
Promising Rationally Derived Combination Therapy with PI3K and CDK4/6 Inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIN D1;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE 4 INHIBITOR;
CYCLIN DEPENDENT KINASE 6;
CYCLIN DEPENDENT KINASE 6 INHIBITOR;
CYCLIN DEPENDENT KINASE INHIBITOR;
FULVESTRANT;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
RETINOBLASTOMA BINDING PROTEIN;
TRANSCRIPTION FACTOR E2F;
UNCLASSIFIED DRUG;
BREAST CANCER CELL LINE;
CELL PROLIFERATION;
CELL SURVIVAL;
COMBINATION CHEMOTHERAPY;
DRUG POTENTIATION;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME INHIBITION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CYCLIN-DEPENDENT KINASE 4;
CYCLIN-DEPENDENT KINASE 6;
FEMALE;
HUMANS;
MUTATION;
PHOSPHATIDYLINOSITOL 3-KINASES;
|
EID: 84904244868
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2014.06.020 Document Type: Short Survey |
Times cited : (11)
|
References (6)
|